Weight loss drugs are still hard to find — but Novo Nordisk and Eli Lilly are trying to change that

[ad_1]

Novo Nordisk and Eli Lilly have given positive supply updates, aiming to reassure investors that they can continue to capitalize on the success of their drugs.

[ad_2]

Source link